A citation-based method for searching scientific literature

D Williams Parsons, Siân Jones, Xiaosong Zhang, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, Hannah Carter, I-Mei Siu, Gary L Gallia, Alessandro Olivi, Roger McLendon, B Ahmed Rasheed, Stephen Keir, Tatiana Nikolskaya, Yuri Nikolsky, Dana A Busam, Hanna Tekleab, Luis A Diaz, James Hartigan, Doug R Smith, Robert L Strausberg, Suely Kazue Nagahashi Marie, Sueli Mieko Oba Shinjo, Hai Yan, Gregory J Riggins, Darell D Bigner, Rachel Karchin, Nick Papadopoulos, Giovanni Parmigiani, Bert Vogelstein, Victor E Velculescu, Kenneth W Kinzler. Science 2008
Times Cited: 3862



Maria E Figueroa, Omar Abdel-Wahab, Chao Lu, Patrick S Ward, Jay Patel, Alan Shih, Yushan Li, Neha Bhagwat, Aparna Vasanthakumar, Hugo F Fernandez, Martin S Tallman, Zhuoxin Sun, Kristy Wolniak, Justine K Peeters, Wei Liu, Sung E Choe, Valeria R Fantin, Elisabeth Paietta, Bob Löwenberg, Jonathan D Licht, Lucy A Godley, Ruud Delwel, Peter J M Valk, Craig B Thompson, Ross L Levine, Ari Melnick. Cancer Cell 2010
Times Cited: 1683




List of shared articles



Times cited

Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite.
Raffaela S Berger, Christian J Wachsmuth, Magdalena C Waldhier, Kathrin Renner-Sattler, Simone Thomas, Anuhar Chaturvedi, Hans-Helmut Niller, Elisabeth Bumes, Peter Hau, Martin Proescholdt,[...]. Cancers (Basel) 2021
0

The Impact of Epigenetic Modifications in Myeloid Malignancies.
Deirdra Venney, Adone Mohd-Sarip, Ken I Mills. Int J Mol Sci 2021
0

Sirtuin activation targets IDH-mutant tumors.
Julie J Miller, Alexandria Fink, Jack A Banagis, Hiroaki Nagashima, Megha Subramanian, Christine K Lee, Lisa Melamed, Shilpa S Tummala, Kensuke Tateishi, Hiroaki Wakimoto,[...]. Neuro Oncol 2021
5

Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice.
Padma Kadiyala, Stephen V Carney, Jessica C Gauss, Maria B Garcia-Fabiani, Santiago Haase, Mahmoud S Alghamri, Felipe J Núñez, Yayuan Liu, Minzhi Yu, Ayman Taher,[...]. J Clin Invest 2021
7

Biological Roles and Therapeutic Applications of IDH2 Mutations in Human Cancer.
Jinxiu Guo, Ruyue Zhang, Zhe Yang, Zhenfeng Duan, Detao Yin, Yubing Zhou. Front Oncol 2021
0

Additional mutations in IDH1/2-mutated patients with acute myeloid leukemia.
Jingtao Lu, Meiyu Chen, Haiying Hua, Wei Qin, Ri Zhang, Xuzhang Lu, Hongying Chao. Int J Lab Hematol 2021
0

Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors.
Antje Wick, Oliver Bähr, Martin Schuler, Kristoffer Rohrberg, Sant P Chawla, Filip Janku, David Schiff, Volker Heinemann, Yoshitaka Narita, Heinz-Josef Lenz,[...]. Clin Cancer Res 2021
1

From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy.
Emanuela Di Gregorio, Gianmaria Miolo, Asia Saorin, Agostino Steffan, Giuseppe Corona. Int J Mol Sci 2021
0

The Crucial Roles of Intermediate Metabolites in Cancer.
Sisi Huang, Zhiqin Wang, Liang Zhao. Cancer Manag Res 2021
0

TNFAIP8 drives metabolic reprogramming to promote prostate cancer cell proliferation.
Suryakant Niture, Minghui Lin, Joab O Odera, John Moore, Hong Zhe, Xiaoxin Chen, Simeng Suy, Sean P Collins, Deepak Kumar. Int J Biochem Cell Biol 2021
0